Tenax Therapeutics is subject to a securities class action lawsuit alleging the company misled investors about the effectiveness of its drug TNX-103. The lawsuit claims the company concealed poor clinical trial results, which were revealed on August 10, 2026, when the drug failed key endpoints in a Phase 3 trial. Following this disclosure, Tenax's stock price dropped nearly 90%, causing significant investor losses. Investors who bought shares between November 2023 and August 2026 may join the class action and have until December 28, 2026, to seek lead plaintiff status.
Tenax Therapeutics, Inc. is the subject of a securities class action lawsuit. For readers following the health sector, here is Pluang's market snapshot as of Oct 28, 2026 19:43 WIB: out of 150 priced health-sector US stocks, 44 rose and 95 fell. Notable movers include ACB at USD 4.44 with a 1-day change of +6.99%, GEHC at USD 75.00 with +5.47%, and INO at USD 0.94 with +5.40% and a Pluang order activity split of 54% Sell / 46% Buy.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
